Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-7678Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-10081Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-11487Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-12664Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-12725Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-13638Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-15053Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-15181Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-15225Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-15938Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-16094Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-16135Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-16296Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-16502Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-16705Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-17291Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-17551Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-17583Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-17938Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-19472Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-19568Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-21509Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-21893Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-22175Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-24024Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-24220Peak area normalizedmale Diabetic no neuropathy

Return to search page
  logo